Health ❯ Mental Health

Psychedelic Therapy

Psilocybin Ibogaine Research PTSD Treatment Clinical Trials MDMA Psychedelic Drugs Substance Use Clinical Research Treatment Options

California Father Pleads Guilty to Dosing Sons and Running Large Psilocybin Operation

The admission could prompt criminal penalties and separate child-welfare action ahead of his September sentencing.

Single High Dose of Psilocybin Linked to Short-Term Brain Changes and Improved Well-Being

Minnesota House Backs Psilocybin Therapy Pilot in Health Budget Bill

Single High Dose of Psilocybin Tied to Lasting Brain Changes and Month-Later Well-Being

White House Orders Fast-Track for Psychedelic Therapies and Limited Cannabis Rescheduling

FDA Clears First U.S. Trial of Ibogaine Derivative After Trump Order

FDA Fast-Tracks Reviews for Psilocybin and Methylone After Trump Order

Trump Orders Faster FDA Reviews of Psychedelics, Credits Joe Rogan for Push

Trump Order to Speed Psychedelic Therapies Sends Compass Pathways to 52-Week High

Trump Orders FDA To Fast-Track Psychedelic Reviews, Sets $50 Million For Ibogaine Research

Trump Orders Faster Reviews and Limited Patient Access for Psychedelics, Spotlighting Ibogaine

Trump Signs Order to Fast-Track Psychedelic Treatments

Trump Signs Order to Speed Psychedelic Research for Veterans

Mega-Analysis Maps Common Brain Signature Across Psychedelics

Largest Brain-Scan Analysis Finds Shared Psychedelic ‘Neural Fingerprint’

Senate Weighs Casey Means for Surgeon General as Questions Mount Over Vaccines, Wellness Business, and Spiritualism

Michael Pollan’s ‘A World Appears’ Probes Consciousness, Questions AI Claims

Psilocybin Therapy Clears Second Phase 3 Test as Compass Pathways Preps FDA Bid

Single IV DMT Dose With Therapy Shows Rapid, Lasting Antidepressant Effect in Phase IIa Trial

Bryan Johnson Livestreams High-Dose Psilocybin Session as Tech Luminaries Tune In